NCT03005340View on ClinicalTrials.gov

A Phase 1 Drug Drug Interaction Clinical Trial of C1-R215 and C2-R215 in Healthy Male Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

June 30, 2017

Conditions
Healthy
Interventions
DRUG

Treatment B

Bazedoxifene 20 mg

DRUG

Treatment C

Cholecalciferol granule 10 mg

DRUG

Treatment BC

Bazedoxifene 20 mg, Cholecalciferol granule 10 mg

Sponsors

Lead Sponsor

Alvogen Korea
All Listed Sponsors
lead

Alvogen Korea

INDUSTRY